Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Primary percutaneous coronary intervention is appropriate in transient ST-elevation myocardial infarction

L. Koc, M. Mikolaskova, T. Novotny, J. Parenica, J. Kanovsky, T. Ondrus, M. Holicka, M. Poloczek, J. Jarkovsky, M. Malik, P. Kala

. 2022 ; 166 (2) : 180-186. [pub] 20210204

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22014556

Grantová podpora
NH/16/2/32499 British Heart Foundation - United Kingdom

INTRODUCTION: Reperfusion therapy by primary percutaneous coronary intervention (PPCI) is generally indicated in patients suffering from acute myocardial infarction (MI) with ST-segment elevation (STEMI). Prior to hospital admission, full ST-segment resolution (fSTR) may occur. Optimal management of such patients with transient STEMI (TSTEMI) is potentially challenging. Our aim was to evaluate the hypothesis that in TSTEMI patients, patency of infarct related artery (IRA) is achieved before PPCI, and to compare the outcome of TSTEMI and STEMI patients during a prolonged follow-up. MATERIAL AND METHODS: Three hundred consecutive adult STEMI patients were referred to catheterization laboratory. In all patients, standard 12 lead ECGs were obtained both at the time of the first medical contact, and on catheterization laboratory admission. RESULTS: TSTEMI occurred in 20 patients (6.7%). Despite fSTR (isoelectric ST segment), occluded IRA was found in 5 of these patients (25%). Pre-PPCI TIMI flow grade 2 was found in 6 TSTEMI patients (30%). Troponin T value at 24 h after symptom onset was lower in the TSTEMI group (1.8±2.5 mg/L vs. 3.6±3.5 mg/L, P=0.008). These patients also had a lower value of brain natriuretic peptide (156.3±119.5 ng/L vs. 438.5±429.0 ng/L, P<0.001) and higher left ventricular ejection fraction (59.9±6.3% vs. 51.6±10.2%, P<0.001). All patients were followed for a median of 5.6 years during which the overall survival did not differ between the TSTEMI and STEMI groups. CONCLUSION: Primary PCI is strongly recommended in TSTEMI patients because of a relatively high incidence of occluded infarct related arteries. The rate of patients with TSTEMI is relatively low.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22014556
003      
CZ-PrNML
005      
20230308085806.0
007      
ta
008      
220602s2022 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2021.005 $2 doi
035    __
$a (PubMed)33542543
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Koc, Lumír $u Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0241362
245    10
$a Primary percutaneous coronary intervention is appropriate in transient ST-elevation myocardial infarction / $c L. Koc, M. Mikolaskova, T. Novotny, J. Parenica, J. Kanovsky, T. Ondrus, M. Holicka, M. Poloczek, J. Jarkovsky, M. Malik, P. Kala
520    9_
$a INTRODUCTION: Reperfusion therapy by primary percutaneous coronary intervention (PPCI) is generally indicated in patients suffering from acute myocardial infarction (MI) with ST-segment elevation (STEMI). Prior to hospital admission, full ST-segment resolution (fSTR) may occur. Optimal management of such patients with transient STEMI (TSTEMI) is potentially challenging. Our aim was to evaluate the hypothesis that in TSTEMI patients, patency of infarct related artery (IRA) is achieved before PPCI, and to compare the outcome of TSTEMI and STEMI patients during a prolonged follow-up. MATERIAL AND METHODS: Three hundred consecutive adult STEMI patients were referred to catheterization laboratory. In all patients, standard 12 lead ECGs were obtained both at the time of the first medical contact, and on catheterization laboratory admission. RESULTS: TSTEMI occurred in 20 patients (6.7%). Despite fSTR (isoelectric ST segment), occluded IRA was found in 5 of these patients (25%). Pre-PPCI TIMI flow grade 2 was found in 6 TSTEMI patients (30%). Troponin T value at 24 h after symptom onset was lower in the TSTEMI group (1.8±2.5 mg/L vs. 3.6±3.5 mg/L, P=0.008). These patients also had a lower value of brain natriuretic peptide (156.3±119.5 ng/L vs. 438.5±429.0 ng/L, P<0.001) and higher left ventricular ejection fraction (59.9±6.3% vs. 51.6±10.2%, P<0.001). All patients were followed for a median of 5.6 years during which the overall survival did not differ between the TSTEMI and STEMI groups. CONCLUSION: Primary PCI is strongly recommended in TSTEMI patients because of a relatively high incidence of occluded infarct related arteries. The rate of patients with TSTEMI is relatively low.
650    _2
$a dospělí $7 D000328
650    _2
$a lidé $7 D006801
650    12
$a infarkt myokardu $x diagnóza $x chirurgie $7 D009203
650    12
$a koronární angioplastika $x škodlivé účinky $7 D062645
650    12
$a infarkt myokardu s elevacemi ST úseků $x chirurgie $7 D000072657
650    _2
$a tepový objem $7 D013318
650    _2
$a výsledek terapie $7 D016896
650    _2
$a funkce levé komory srdeční $7 D016277
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mikolášková, Monika $u Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0236401
700    1_
$a Novotný, Tomáš, $u Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $d 1969- $7 xx0055126
700    1_
$a Pařenica, Jiří $u Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0101388
700    1_
$a Kaňovský, Jan $u Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0211167
700    1_
$a Ondrúš, Tomáš $u Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0258976
700    1_
$a Holická, Mária $u Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $7 xx0268582
700    1_
$a Poloczek, Martin $u Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic $7 xx0101387
700    1_
$a Jarkovský, Jiří, $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $d 1976- $7 stk2008461294
700    1_
$a Malík, Marek, $u National Heart and Lung Institute, Imperial College of London, London, United Kingdom $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $d 1951- $7 xx0098959
700    1_
$a Kala, Petr, $u Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $d 1965- $7 xx0043092
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x 1213-8118 $g Roč. 166, č. 2 (2022), s. 180-186
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33542543 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20220602 $b ABA008
991    __
$a 20230308085801 $b ABA008
999    __
$a ok $b bmc $g 1824811 $s 1165777
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 166 $c 2 $d 180-186 $e 20210204 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
GRA    __
$a NH/16/2/32499 $p British Heart Foundation $2 United Kingdom
LZP    __
$b NLK198 $a Pubmed-20220602

Najít záznam

Citační ukazatele

Možnosti archivace